Literature DB >> 11272405

Radiosensitization of a mouse melanoma by withaferin A: in vivo studies.

P U Devi1, R Kamath, B S Rao.   

Abstract

The radiosensitizing effect of a plant withanolide, withaferin A, on the B16F1 mouse melanoma was studied in vivo. Treatment of 100 mm3 tumours with 10 to 60 mg/kg withaferin A intraperitoneally produced a dose dependent increase in growth delay and volume doubling time. Injection of 30-50 mg/kg withaferin A, followed by 30 Gy local gamma irradiation, significantly enhanced the tumour response. No systemic or local adverse reactions were noted in these groups. The drug was most effective when injected intraperitoneally 1 h before irradiation. However, neither the individual agents nor their combination could produce any complete response (tumour cure). Melanoma is a relatively radioresistant tumour. The present results indicate that the radiation response of this tumour can be significantly enhanced by pretreatment with withaferin A.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11272405

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  21 in total

1.  Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.

Authors:  Joomin Lee; Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Carcinogenesis       Date:  2010-08-19       Impact factor: 4.944

2.  Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.

Authors:  Silvia D Stan; Eun-Ryeong Hahm; Renaud Warin; Shivendra V Singh
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

3.  Antiproliferation potential of withaferin A on human osteosarcoma cells via the inhibition of G2/M checkpoint proteins.

Authors:  Ting-Zhuo Lv; Guang-Shun Wang
Journal:  Exp Ther Med       Date:  2015-05-07       Impact factor: 2.447

4.  Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression.

Authors:  Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Cancer Lett       Date:  2012-08-27       Impact factor: 8.679

5.  Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation.

Authors:  Patrick T Grogan; Jann N Sarkaria; Barbara N Timmermann; Mark S Cohen
Journal:  Invest New Drugs       Date:  2014-04-10       Impact factor: 3.850

6.  Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model.

Authors:  Eun-Ryeong Hahm; Joomin Lee; Su-Hyeong Kim; Anuradha Sehrawat; Julie A Arlotti; Sruti S Shiva; Rohit Bhargava; Shivendra V Singh
Journal:  J Natl Cancer Inst       Date:  2013-07-02       Impact factor: 13.506

Review 7.  Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.

Authors:  Avani R Vyas; Shivendra V Singh
Journal:  AAPS J       Date:  2013-09-18       Impact factor: 4.009

8.  Withaferin A targets heat shock protein 90 in pancreatic cancer cells.

Authors:  Yanke Yu; Adel Hamza; Tao Zhang; Mancang Gu; Peng Zou; Bryan Newman; Yanyan Li; A A Leslie Gunatilaka; Chang-Guo Zhan; Duxin Sun
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

9.  Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.

Authors:  Joomin Lee; Anuradha Sehrawat; Shivendra V Singh
Journal:  Breast Cancer Res Treat       Date:  2012-09-11       Impact factor: 4.872

10.  Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells.

Authors:  Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Curr Cancer Drug Targets       Date:  2013-07       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.